Filter
3403
Filtered Results: 3403
Text search:
health
facility
survey
Featured
Recommendations
249
New Publications
1200
Language
Document type
No document type
2233
Studies & Reports
504
Guidelines
324
Strategic & Response Plan
129
Manuals
122
Training Material
31
Fact sheets
26
Situation Updates
20
Resource Platforms
5
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Kenya
182
India
172
Ethiopia
140
Nepal
134
Nigeria
106
Uganda
104
Malawi
102
Sierra Leone
95
Rwanda
92
Global
90
Liberia
85
Zambia
81
Tanzania
73
Ghana
72
South Africa
72
Bangladesh
71
Myanmar / Burma
63
Namibia
53
Africa
46
Philippines
38
Cambodia
37
Western and Central Europe
36
Lesotho
35
Latin America and the Carribbean
35
Congo, Democratic Republic of
34
Syria
34
Zimbabwe
33
Ukraine
33
Senegal
32
Botswana
28
Indonesia
27
Mozambique
26
Asia
23
Eastern Europe
23
South Sudan
20
Haiti
19
Burkina Faso
18
Cameroon
18
South–East Asia Region
18
East and Southern Africa
17
Pakistan
16
Afghanistan
15
Benin
15
Eswatini/ Swaziland
15
Guinea
13
West and Central Africa
12
Russia
11
Middle East and North Africa
10
Yemen
9
Mali
8
Germany
8
Jordan
7
Lebanon
7
Central African Republic
7
Sudan
6
Brazil
6
Laos
6
Somalia
5
Madagascar
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Venezuela
5
Vietnam
5
Turkey
4
Papua New Guinea
4
Burundi
4
Sri Lanka
4
Tajikistan
4
Moldova
4
Iraq
3
Mexico
3
Palestine
3
Albania
3
Southern Africa
3
Timor Leste/ East Timor
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
USA
2
Niger
2
Thailand
2
Gambia
2
China
2
Colombia
2
Ecuador
2
Angola
2
Guatemala
2
Paraguay
2
Bhutan
2
Georgia
2
Turkmenistan
2
France
2
Mauritius
2
Egypt
1
Ireland
1
Singapore
1
Argentina
1
Peru
1
North Macedonia
1
Serbia
1
Bolivia
1
Greece
1
Other region
1
Fiji
1
Poland
1
Mongolia
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Lithuania
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
North America
1
Gabon
1
Denmark
1
Maldives
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1915
Clinical Guidelines
187
Women & Child Health
162
Public Health
146
Key Resources
144
Capacity Building
51
Pharmacy & Technologies
17
Toolboxes
HIV
241
COVID-19
207
TB
181
Mental Health
127
AMR
118
Disability
102
Caregiver
94
Conflict
77
Ebola
67
Planetary Health
63
Pharmacy
49
NTDs
48
Rapid Response
47
NCDs
44
Refugee
29
Global Health Education
28
Natural Hazards
25
Polio
21
Health Financing Toolbox
20
Cholera
13
Specific Hazards
10
Zika
6
Social Ethics
4
Typhoon
2
The following protocol has been designed to investigate the extent of infection, as determined by seropositivity in the general population, in any country in which COVID-19 virus infection has been reported. Each country may need to tailor some aspects of this protocol to align with public ..., laboratory and clinical systems, according to capacity, availability of resources and cultural appropriateness. However, using a standardized protocol such as this one below, epidemiological exposure data and biological samples can be systematically collected and shared rapidly in a format that can be easily aggregated, tabulated and analyzed across many different settings globally for timely estimates of COVID-19 virus infection severity and attack rates, as well as to inform public health responses and policy decisions. This is particularly important in the context of a novel respiratory pathogen, such as COVID-19 virus
The 12th Meeting of the Regional Certification Commission (RCC) for the Polio Endgame in the Region of the Americas was conducted virtually due to the pandemic of COVID-19. The meeting was composed of 5 steps:
Step 1: An introductory meeting between RCC members and Secretariat
Step 2: Assessment...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on trends are also included. The limitations of low-birth-weight data are described and recommendations a...
Annex 5, WHO Technical Report Series 1010, 2018
Saving Lives Through Safe Surgery (SaLTS)
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
To improve the quality of care during labour and childbirth, facilitate effective implementation of the World Health Organization (WHO) recommendations: Intrapartum care for a positive childbirth experience, published in 2018, and promote a shift to...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
Background
Noncommunicable diseases are major contributors to morbidity and mortality worldwide. Modifying the risk factors for these conditions, such as physical inactivity, is thus essential. Addressing the context or circumstances in which physical activity occurs may promote physical activity a...
The document, "Sustainable Management of Radiotherapy Facilities and Equipment," by WHO and IAEA, provides guidelines for managing radiotherapy equipment and facilities to ensure effective and safe cancer treatment. It covers essential aspects like preventive and corrective maintenance, funding, inf...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
Formation sur le suivi et l’évaluation épidémiologique du traitement médicamenteux de masse pour l’élimination de la filariose lymphatique : guide des apprenants. Organisation mondiale de la Santé.
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and ...
